Amrou Awaysheh, an IU Kelley School of Business assistant professor of operations management, is building an IoT-based system he says can save factories $100 million annually in verified energy savings.
The measures are largely focused on ending surprise billing for patients, creating an all-payer claims database and requiring health care providers to give patients costs estimates in advance.
The Indianapolis drugmaker quietly terminated a collaboration with NextCure Inc. after spending $40 million on an up-front fee and equity investment, and with little to show from the partnership.
Finding out why people leave is important. Finding out before they leave why they might be disengaged does a lot more for your workforce and your business.
Most of the biggest gifts of 2019 went to higher education institutions outside the Circle City, but not-for-profits in the Indianapolis area did snag a few seven-figure donations. Here are the top four local gifts. $5 million Recipient: Butler University Donors: Craig Fenneman and Mary Stover-Fenneman For: Several projects, including the upcoming expansion and renovation […]
Pete Buttigieg’s demotion of South Bend’s first African American police chief has shadowed his presidential campaign, giving rise to complaints he has a blind spot on race and raising questions about whether he can attract the support of African Americans who are crucial to earning the Democratic nomination.
The move is the latest of numerous staff changes Nexstar Media Group has made since acquiring the Indianapolis television station less than four months ago.
Host Mason King talks with Bill Soards, president of AT&T Indiana, and Sean Hendrix, who is the director of emerging technologies and partnerships for Purdue Research Foundation, about why 5G matters and how it could be used in the manufacturing, agricultural and other sectors.
Investors couldn’t have asked for much more in 2019, as the decade-long economic expansion rolled on. But don’t expect the same in 2020, analysts warn.
Analysts have said that Dermira’s lead pipeline product, lebrikizumab, has the potential to be the best in class among a wave of similar antibodies to treat eczema.
